StockData
Adagio Medical Holdings, Inc. logo

Adagio Medical Holdings, Inc. (ADGM) stock

ADGMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$1.52−0.13 (-7.88%)

Close on Nov 18, 2026Market cap $1.27MP/E –Yield –

Adagio Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Adagio Medical's operating income for the twelve months ending Sep 30, 2026 was -$18.47M. For fiscal 2025 it was -$21.89M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.89M–
FY2023Dec 31, 2023-$27.94M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$4.37M–
Q2 FY2026Jun 30, 2026-$4.93M–
Q1 FY2026Mar 31, 2026-$5.20M–
Q4 FY2025Dec 31, 2025-$3.97M–
Q3 FY2025Sep 30, 2025-$5.72M–
Q2 FY2025Jun 30, 2025-$4.72M–
Q1 FY2025Mar 31, 2025-$7.40M–
Q2 FY2024Jun 30, 2024-$6.66M–
Q1 FY2024Mar 31, 2024-$8.82M–
Q4 FY2023Dec 31, 2023-$5.33M–
Q3 FY2023Sep 30, 2023-$9.08M–

More Adagio Medical figures

See a number that looks wrong?